Literature DB >> 6969580

Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains.

M Toda, K Sato, H Nakazawa, M Inoue, S Mitsuhashi.   

Abstract

N-Formimidoyl thienamycin (MK0787) was active against beta-lactamase-producing strains and was an effective inhibitor of beta-lactamases extracted and purified from these strains except for plasmid-mediated penicillinase type IV.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6969580      PMCID： PMC284101          DOI： 10.1128/AAC.18.5.837

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Plasmid-mediated penicillin beta-lactamases in Pseudomonas aeruginosa.

Authors:  Y Sawada; S Yaginuma; M Tai; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Biochemical properties of a penicillin beta-lactamase mediated by R factor from Bordetella bronchiseptica.

Authors:  S Yaginuma; N Terakado; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

3.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  A spectrophotometric assay of beta-lactamase action on penicillins.

Authors:  S G Waley
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

5.  Beta-lactamase formation and resistance of Proteus morganii to various penicillins and cephalosporins.

Authors:  S Yaginuma; T Sawai; S Yamagishi; S Mitsuhashi
Journal:  Jpn J Microbiol       Date:  1974-03

6.  Comparison of assay techniques for beta-lactamase activity.

Authors:  G W Ross; K V Chanter; A M Harris; S M Kirby; M J Marshall; C H O'Callaghan
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

7.  Variant of penicillinase mediated by an R factor in Escherichia coli.

Authors:  T Sawai; K Takahashi; S Yamagishi; S Mitsuhashi
Journal:  J Bacteriol       Date:  1970-11       Impact factor: 3.490

8.  In vitro activity of thienamycin.

Authors:  F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

9.  The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli.

Authors:  S Yamagishi; K O'Hara; T Sawai; S Mitsuhashi
Journal:  J Biochem       Date:  1969-07       Impact factor: 3.387

10.  Purification and properties of beta-lactamase from Proteus morganii.

Authors:  Y Fujii-Kuriyama; M Yamamoto; S Sugawara
Journal:  J Bacteriol       Date:  1977-09       Impact factor: 3.490
View more
  17 in total

1.  In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.

Authors:  Z Pusztai-Markos; F Pranada
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

2.  Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.

Authors:  Y Saino; F Kobayashi; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

3.  The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.

Authors:  G Tischhauser; F H Kayser
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

Review 4.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci.

Authors:  R M Blumenthal; R Raeder; C D Takemoto; E H Freimer
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

6.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.

Authors:  F Kobayashi; Y Saino; T Koshi; Y Hattori; M Nakayama; A Iwasaki; T Mori; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

Review 8.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

9.  A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.

Authors:  W Cullmann; W Opferkuch; M Stieglitz; U Werkmeister
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  Properties of a new penicillinase type produced by Bacteroides fragilis.

Authors:  K Sato; Y Matsuura; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.